Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC (PSMA-11) in tumor and normal tissue

Janet Pollard, Caleb Raman, Yousef Zakharia, Chad R. Tracy, Kenneth G. Nepple, Tim Ginader, Patrick Breheny and John Sunderland
Journal of Nuclear Medicine December 2019, jnumed.119.236083; DOI: https://doi.org/10.2967/jnumed.119.236083
Janet Pollard
1 University of Iowa Hospitals and Clinics, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Janet Pollard
Caleb Raman
2 University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yousef Zakharia
1 University of Iowa Hospitals and Clinics, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chad R. Tracy
1 University of Iowa Hospitals and Clinics, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth G. Nepple
1 University of Iowa Hospitals and Clinics, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Ginader
2 University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Breheny
2 University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Sunderland
1 University of Iowa Hospitals and Clinics, United States;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.236083
DOI 
https://doi.org/10.2967/jnumed.119.236083
PubMed 
31806776

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 5, 2019.

Article Versions

  • You are currently viewing a previous version of this article (December 5, 2019 - 10:37).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Janet Pollard1,
  2. Caleb Raman2,
  3. Yousef Zakharia1,
  4. Chad R. Tracy1,
  5. Kenneth G. Nepple1,
  6. Tim Ginader2,
  7. Patrick Breheny2 and
  8. John Sunderland1
  1. 1 University of Iowa Hospitals and Clinics, United States;
  2. 2 University of Iowa
  1. For correspondence or reprints contact: Janet Pollard, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242, United States. E-mail: janet-pollard@uiowa.edu

Statistics from Altmetric.com

Cited By...

  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
    Francesco Ceci, Daniela E. Oprea-Lager, Louise Emmett, Judit A. Adam, Jamshed Bomanji, Johannes Czernin, Matthias Eiber, Uwe Haberkorn, Michael S. Hofman, Thomas A. Hope, Rakesh Kumar, Steven P. Rowe, Sarah M. Schwarzenboeck, Stefano Fanti, Ken Herrmann
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 5
  • Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
    Stefano Fanti, Karolien Goffin, Boris A Hadaschik, Ken Herrmann, Tobias Maurer, Steven MacLennan, Daniela E. Oprea-Lager, Wim JG Oyen, Olivier Rouvière, Nicolas Mottet, Anders Bjartell
    European Journal of Nuclear Medicine and Molecular Imaging 2021 48 2
  • Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    Robert Seifert, Louise Emmett, Steven P. Rowe, Ken Herrmann, Boris Hadaschik, Jeremie Calais, Frederik L. Giesel, Robert Reiter, Tobias Maurer, Matthias Heck, Andrei Gafita, Michael J. Morris, Stefano Fanti, Wolfgang A. Weber, Thomas A. Hope, Michael S. Hofman, Wolfgang Peter Fendler, Matthias Eiber
    European Urology 2023 83 5
  • Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
    Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler, Matthias Eiber
    Journal of Nuclear Medicine 2022 63 2
  • Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography
    Daniela E. Oprea-Lager, Matthijs C.F. Cysouw, Ronald Boellaard, Christophe M. Deroose, Lioe-Fee de Geus-Oei, Egesta Lopci, Luc Bidaut, Ken Herrmann, Laure S. Fournier, Tobias Bäuerle, Nandita M. deSouza, Frederic E. Lecouvet
    Frontiers in Oncology 2021 11
  • Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
    Odrade Gondry, Vicky Caveliers, Catarina Xavier, Laurens Raes, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, Katrien Glorieus, Jacques De Grève, Sofie Joris, Ine Luyten, Karen Zwaenepoel, Frederik Vandenbroucke, Wim Waelput, Sheeno Thyparambil, Ilse Vaneycken, Julie Cousaert, Sophie Bourgeois, Nick Devoogdt, Lode Goethals, Hendrik Everaert, Frank De Geeter, Tony Lahoutte, Marleen Keyaerts
    Journal of Nuclear Medicine 2024 65 2
  • The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
    Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin, Jeremie Calais
    Journal of Nuclear Medicine 2021 62 9
  • Day-to-day variability of [68Ga]Ga-PSMA-11 accumulation in primary prostate cancer: effects on tracer uptake and visual interpretation
    Judith olde Heuvel, Berlinda J. de Wit-van der Veen, Maarten L. Donswijk, Cornelis H. Slump, Marcel P. M. Stokkel
    EJNMMI Research 2020 10 1
  • Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images
    Jake Kendrick, Roslyn J Francis, Ghulam Mubashar Hassan, Pejman Rowshanfarzad, Jeremy SL Ong, Michael McCarthy, Sweeka Alexander, Martin A Ebert
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 13
  • High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL
    Rudolf A. Werner, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Takahiro Higuchi, Philipp Hartrampf, Sebastian E. Serfling, Thorsten Derlin, Constantin Lapa, Andreas K. Buck, Markus Essler, Kenneth J. Pienta, Mario A. Eisenberger, Mark C. Markowski, Laura Shinehouse, Rehab AbdAllah, Ali Salavati, Martin A. Lodge, Martin G. Pomper, Michael A. Gorin, Ralph A. Bundschuh, Steven P. Rowe
    Molecular Imaging 2022 2022

Article usage

Article usage: December 2019 to April 2025

AbstractFullPdf
Dec 2019473046
Jan 2020133016
Feb 202010806
Mar 20209308
Apr 20209205
May 202053011
Jun 202056016
Jul 202050038
Aug 20209131869
Sep 2020272535
Oct 2020132211
Nov 202098510
Dec 2020108314
Jan 202112368
Feb 2021496336
Mar 2021397548
Apr 2021217232
May 2021239819
Jun 2021216421
Jul 2021233726
Aug 2021122814
Sep 2021142320
Oct 2021113141
Nov 2021123433
Dec 2021133010
Jan 2022212714
Feb 2022192813
Mar 2022312823
Apr 2022142920
May 2022233129
Jun 2022123115
Jul 202263923
Aug 2022103117
Sep 202272114
Oct 20228249
Nov 202282514
Dec 202211188
Jan 2023113611
Feb 2023132615
Mar 202344113
Apr 2023152716
May 2023162418
Jun 202351513
Jul 202333113
Aug 202371912
Sep 202351911
Oct 202393115
Nov 2023102912
Dec 202373715
Jan 2024105019
Feb 202482116
Mar 202453456
Apr 20241330135
May 202475925
Jun 202452415
Jul 2024103011
Aug 2024274959
Sep 2024152719
Oct 202483428
Nov 202453718
Dec 20248379
Jan 202531315
Feb 20251710515
Mar 202595026
Apr 202575521
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC (PSMA-11) in tumor and normal tissue
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC (PSMA-11) in tumor and normal tissue
Janet Pollard, Caleb Raman, Yousef Zakharia, Chad R. Tracy, Kenneth G. Nepple, Tim Ginader, Patrick Breheny, John Sunderland
Journal of Nuclear Medicine Dec 2019, jnumed.119.236083; DOI: 10.2967/jnumed.119.236083

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quantitative test-retest measurement of 68Ga-PSMA-HBED-CC (PSMA-11) in tumor and normal tissue
Janet Pollard, Caleb Raman, Yousef Zakharia, Chad R. Tracy, Kenneth G. Nepple, Tim Ginader, Patrick Breheny, John Sunderland
Journal of Nuclear Medicine Dec 2019, jnumed.119.236083; DOI: 10.2967/jnumed.119.236083
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: GU)

  • Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
  • A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
  • Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
Show more Clinical (Oncology: GU)

Similar Articles

Keywords

  • Oncology: GU
  • PET/CT
  • radiopharmaceuticals
  • PSMA HBED-CC
  • PSMA-11
  • SUV
  • repeatability
SNMMI

© 2025 SNMMI

Powered by HighWire